Loading…
Loading…

| ABBVABBVAbbVie Inc. | AbbVie Inc. | $266.79 | $471.4B |
| MRKMRKMerck & Co., Inc. | Merck & Co., Inc. | $141.93 | $350.5B |
| NVSNVSNovartis AG | Novartis AG | $140.79 | $267.6B |
| AZNAZNAstraZeneca PLC | AstraZeneca PLC | $158.61 | $246.0B |
| AMGNAMGNAmgen Inc. | Amgen Inc. | $402.60 | $217.3B |
| GILDGILDGilead Sciences, Inc. | Gilead Sciences, Inc. | $144.23 | $178.8B |
| PFEPFEPfizer Inc. | Pfizer Inc. | $27.49 | $156.6B |
| BMYBMYBristol-Myers Squibb Company | Bristol-Myers Squibb Company | $59.59 | $121.7B |
| SNYSNYSanofi | Sanofi | $39.56 | $95.0B |
| GSKGSKGSK plc | GSK plc | $46.60 | $93.4B |